-+ 0.00%
-+ 0.00%
-+ 0.00%

Goldman Sachs Maintains Buy on Legence, Raises Price Target to $72

Benzinga·04/16/2026 11:44:07
Listen to the news
Goldman Sachs analyst Adam Bubes maintains Legence (NASDAQ:LGN) with a Buy and raises the price target from $63 to $72.